Changes in the content of glutamate and GABA in the cerebellar vermis and hemispheres of the Purkinje cell degeneration (pcd) mutant
- PMID: 2896308
- DOI: 10.1007/BF00973323
Changes in the content of glutamate and GABA in the cerebellar vermis and hemispheres of the Purkinje cell degeneration (pcd) mutant
Abstract
The contents of glutamate and GABA, as well as aspartate, glycine, and alanine, were examined in the cerebellar vermis and hemispheres of normal and Purkinje cell degeneration (pcd) mutant mice at 6, 9, and 12 months of age. Relative to normal values, the content of glutamate was approximately 50% lower in the vermis for the 3 age groups. In the hemispheres, the content of glutamate was also lower than control values and showed a progressive loss from 30 to 47% with age. On the other hand, in the case of GABA in the vermis, the level was 39% lower in the pcd mutant at 6 months of age but no different from control values at 12 months. However, relative to data for normal mice, the content of GABA in the hemispheres was consistently lower (20%) for all age groups. The level of aspartate was approximately 60% lower in the cerebellar vermis and 45 to 55% lower in the hemispheres of the mutant with respect to control data for all three age groups. Likewise, alanine showed a reduced content in the hemispheres (36-46%) and vermis (24%) in the mutant relative to normal values at 6, 9, and 12 months of age. On the other hand, the level of glycine was 43-64% higher in the vermis and 77-100% greater in the hemispheres of the mutant than in the control group. The higher values for glycine were observed at the two oldest ages. In conclusions, the data are consistent with the idea that glutamate and GABA are present in high concentrations in granule and Purkinje cells, respectively, and provide additional support for a transmitter function for both amino acids in the cerebellum.
Similar articles
-
Neurochemical and morphological consequences of axon terminal degeneration in cerebellar deep nuclei of mice with inherited Purkinje cell degeneration.Brain Res. 1979 May 18;168(1):75-95. doi: 10.1016/0006-8993(79)90129-x. Brain Res. 1979. PMID: 455087
-
Cerebellar benzodiazepine receptors: cellular localization and consequences of neurological mutations in mice.Brain Res. 1988 Mar 15;444(1):133-46. doi: 10.1016/0006-8993(88)90920-1. Brain Res. 1988. PMID: 2834020
-
Differential number of glycine- and GABA-immunopositive neurons and terminals in the deep cerebellar nuclei of normal and Purkinje cell degeneration mutant mice.J Comp Neurol. 1997 Jun 16;382(4):443-58. J Comp Neurol. 1997. PMID: 9184992
-
Cultured neurons as model systems for biochemical and pharmacological studies on receptors for neurotransmitter amino acids.Dev Neurosci. 1985;7(5-6):252-62. doi: 10.1159/000112294. Dev Neurosci. 1985. PMID: 2873018 Review.
-
The Purkinje cell degeneration (pcd) mouse: an unexpected molecular link between neuronal degeneration and regeneration.Brain Res. 2007 Apr 6;1140:26-40. doi: 10.1016/j.brainres.2006.07.065. Epub 2006 Aug 30. Brain Res. 2007. PMID: 16942761 Review.
Cited by
-
The effects of two anticonvulsants on amino acid levels in the developing rat cerebellum.Neurochem Res. 1989 May;14(5):427-9. doi: 10.1007/BF00964856. Neurochem Res. 1989. PMID: 2568591
-
Stabilisation of neurone number in the inferior olivary complex of aged 'Purkinje cell degeneration' mutant mice.Acta Neuropathol. 1991;81(6):597-602. doi: 10.1007/BF00296368. Acta Neuropathol. 1991. PMID: 1882635
-
CCP1/Nna1 functions in protein turnover in mouse brain: Implications for cell death in Purkinje cell degeneration mice.FASEB J. 2010 Jun;24(6):1813-23. doi: 10.1096/fj.09-147942. Epub 2010 Jan 8. FASEB J. 2010. PMID: 20061535 Free PMC article.